A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM
1 other identifier
interventional
82
1 country
1
Brief Summary
R34-funded study to pilot test an intervention to improve coping with discrimination and adherence among Latino men who have sex with men (MSM) living with HIV. The proposed research aims to modify and refine Siempre Seguiré, a culturally congruent cognitive behavior therapy group intervention for HIV-positive Latino men who have sex with men (LMSM), to include strategies for ART adherence and retention in HIV care; and to conduct a small randomized pilot of Siempre Seguiré to examine feasibility and acceptability, as well as to explore preliminary effects on coping responses to discrimination and antiretroviral treatment adherence among LMSM living with HIV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Mar 2018
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2018
CompletedFirst Posted
Study publicly available on registry
February 14, 2018
CompletedStudy Start
First participant enrolled
March 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2019
CompletedResults Posted
Study results publicly available
February 25, 2021
CompletedMarch 29, 2023
March 1, 2023
1.5 years
January 31, 2018
November 18, 2020
March 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Continuous Adherence (MEMS)
Percentage of doses taken, of those prescribed, from electronic monitoring
4-5 and 6-7 months post-baseline
Continuous Adherence (Self-report)
Percentage of doses taken, of those prescribed, self-report
4 and 7 months post-baseline
Secondary Outcomes (8)
Functional Coping Strategies
4 and 7 months post-baseline
Positive Religious Coping Strategies
4 and 7 months post-baseline
Dysfunctional Coping Strategies
4 and 7 months post-baseline
Negative Religious Coping Strategies
4 and 7 months post-baseline
Medical Mistrust (General)
4 and 7 months post-baseline
- +3 more secondary outcomes
Study Arms (2)
Siempre Seguiré
EXPERIMENTALWe will conduct a small randomized controlled trial (RCT), testing study protocols and materials, the acceptability of randomization, and overall program feasibility. The pilot will help to identify logistical considerations; assess whether the program is acceptable and understandable LMSM; and collect initial data on how successfully the program motivates change in coping and adherence. It will allow us to estimate expected attrition and response rates, and to perform preliminary power analyses in preparation for a fully powered RCT.
Control
NO INTERVENTIONControl participants will not be randomized to receive the intervention and will receive standard of care during the intervention period. We will offer the program to any interested control participants shortly after the 6-month follow-up surveys are completed.
Interventions
A culturally congruent CBT group intervention for HIV-positive LMSM, to include strategies for ART adherence and retention in HIV care.
Eligibility Criteria
You may qualify if:
- Age 18 years-old or older, HIV-positive, biologically male at birth and continue to identify as male, identify as Latino, report having sex with men in the past 12 months, and prescribed ART.
You may not qualify if:
- Being unwilling or unable to provide informed consent; having mental health problems that require immediate treatment (e.g., psychotic symptoms) or a diagnosed mental disorder that would limit ability to participate (e.g., dementia); and cognitive impairments that result in limited ability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RANDlead
- Bienestar Human Services, Inc.collaborator
Study Sites (1)
Bienestar Human Services, Inc.
Los Angeles, California, 90022, United States
Related Publications (2)
Barreras JL, Bogart LM, MacCarthy S, Klein DJ, Pantalone DW. Discrimination and adherence in a cross-sectional study of Latino sexual minority men with HIV: Coping with discrimination as a mediator and coping self-efficacy as a moderator. J Behav Med. 2023 Dec;46(6):1057-1067. doi: 10.1007/s10865-023-00426-6. Epub 2023 Jul 1.
PMID: 37392342DERIVEDBogart LM, Barreras JL, Gonzalez A, Klein DJ, Marsh T, Agniel D, Pantalone DW. Pilot Randomized Controlled Trial of an Intervention to Improve Coping with Intersectional Stigma and Medication Adherence Among HIV-Positive Latinx Sexual Minority Men. AIDS Behav. 2021 Jun;25(6):1647-1660. doi: 10.1007/s10461-020-03081-z. Epub 2020 Nov 24.
PMID: 33231847DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Bogart, PhD
- Organization
- RAND Corporation
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Bogart, PhD
RAND
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 14, 2018
Study Start
March 27, 2018
Primary Completion
September 12, 2019
Study Completion
September 16, 2019
Last Updated
March 29, 2023
Results First Posted
February 25, 2021
Record last verified: 2023-03